Alpa Laboratories [ALPA] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Alpa Laboratories Ltd.

NSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Alpa Laboratories Ltd. wins in 4 metrics, Sun Pharmaceutical Industries Ltd. wins in 14 metrics, with 1 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Alpa Laboratories Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 12.42 36.73 Alpa Laboratories Ltd.
Price-to-Book Ratio 0.84 5.15 Alpa Laboratories Ltd.
Debt-to-Equity Ratio 0.00 6.68 Tie
PEG Ratio -0.16 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA -27.38 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) 10.15% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 2.97% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 2.97% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 11.38% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 8.76% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-43.22M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -27.93% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.26 7.05 Alpa Laboratories Ltd.
Enterprise Value $59.77M $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 0.05 6.66 Alpa Laboratories Ltd.
Gross Profit Margin (TTM) 25.74% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $54 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $5.52 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.76 0.11 Sun Pharmaceutical Industries Ltd.

Alpa Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

ALPA
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alpa Laboratories Ltd.-0.39%-2.26%2.63%9.59%-20.28%-12.34%
Sun Pharmaceutical Industries Ltd.-0.47%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alpa Laboratories Ltd.-27.93%16.22%27.20%137.67%567.48%39.22%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Alpa Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricALPASUNPHARMA
Market Information
Market Cap i₹1.44B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i24,0203,903,142
90 Day Avg. Volume i39,7793,253,866
Last Close₹68.84₹1,780.10
52 Week Range₹46.10 - ₹108.30₹1,548.00 - ₹1,916.60
% from 52W High-36.44%-7.12%
All-Time High₹144.50 (Sep 30, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-52.36%-9.19%
Growth Metrics
Quarterly Revenue Growth0.11%0.14%
Quarterly Earnings Growth-0.79%0.16%
Financial Health
Profit Margin (TTM) i0.10%0.19%
Operating Margin (TTM) i0.03%0.26%
Return on Equity (TTM) i0.11%0.15%
Debt to Equity (MRQ) i0.006.68
Cash & Liquidity
Book Value per Share (MRQ)₹81.47₹324.46
Cash per Share (MRQ)₹65.73₹115.87
Operating Cash Flow (TTM) i₹11.72M₹110.84B
Levered Free Cash Flow (TTM) i₹195.03M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Alpa Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricALPA (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i12.4236.73
Forward P/E i12.9629.48
PEG Ratio i-0.163.59
Price to Sales (TTM) i1.267.05
Price to Book (MRQ) i0.845.15
Market Capitalization
Market Capitalization i₹1.44B₹3.88T
Enterprise Value i₹59.77M₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i0.056.66
Enterprise to EBITDA i-27.3823.61
Risk & Other Metrics
Beta i0.760.11
Book Value per Share (MRQ) i₹81.47₹324.46

Financial Statements Comparison: Alpa Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALPA (2025)SUNPHARMA (2025)
Revenue/Sales i1.12B520.41B
Cost of Goods Sold i760.44M121.98B
COGS % of Revenue i68.1%23.4%
Gross Profit i355.91M398.44B
Gross Margin i31.9%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i34.55M125.81B
Operating Margin i3.1%24.2%
EBITDA i90.25M167.25B
EBITDA Margin i8.1%32.1%
Pre-Tax Income i256.67M137.52B
Pre-Tax Income % of Revenue i23.0%26.4%
Income Tax i61.64M27.72B
Income Tax % of Revenue i5.5%5.3%
Net Income (Profit) i195.03M109.65B
Profit Margin i17.5%21.1%

Balance Sheet & Liquidity Metrics

MetricALPA (2025)SUNPHARMA (2025)
Cash & Equivalents i22.22M102.69B
Total Current Assets i1.92B526.24B
Total Current Assets % of Revenue i172.4%101.1%
Total Current Liabilities i467.00M181.94B
Total Current Liabilities % of Revenue i41.8%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i1.71B724.86B
Retained Earnings i954.33M578.62B
Retained Earnings % of Revenue i85.5%111.2%
Property, Plant & Equipment i61.19M100.36B

Cash Flow Statement Comparison

MetricALPA (2025)SUNPHARMA (2025)
Operating Cash Flow i11.72M110.84B
Operating Cash Flow % of Revenue i1.0%21.3%
Capital Expenditures i-113.80M-20.68B
Free Cash Flow i-43.22M119.44B
FCF Margin i-3.9%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricALPASUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i21.04M2.40B
Float Shares i9.01M1.07B
% Held by Insiders i57.29%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i42.71%15.69%

Dividend Analysis & Yield Comparison: Alpa Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricALPASUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026